Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia is a severe psychiatric disorder with complex pathophysiology, high mortality, and significant disability.
• Early detection and intervention are crucial for managing schizophrenia.
• Previous research indicated altered NPTX2 expression in schizophrenia brains.

Purpose of the Study:

• To perform a meta-analysis of gene expression datasets in peripheral tissues of schizophrenia patients and healthy controls.
• To identify consistent patterns of illness-associated gene expression.
• To investigate if NPTX2 downregulation in schizophrenia brains is replicated in peripheral tissues.

Main Methods:

• Systematic search of the Gene Expression Omnibus repository for relevant datasets.
• Inclusion of 3 datasets (GSE62333, GSE18312, GSE27383) after quality control.
• Meta-analysis using the GeneMeta package with a total sample size of 71 schizophrenia patients and 57 healthy controls.

Main Results:

• Meta-analysis revealed significant differential expression for two genes: atlastin GTPase 3 (ATL3) was upregulated (FDR < 0.05) and arachidonate 15-lipoxygenase, type B (ALOX15B) was downregulated (FDR < 0.05).
• The upregulation of ATL3 was confirmed using the weighted Z test.
• A suggestive downregulation signal for ALOX15B was observed (FDR < 0.10).

Conclusions:

• Peripheral expression of ATL3 is altered in schizophrenia.
• The study did not confirm a significant association signal for NPTX2 in peripheral tissues, unlike in postmortem brain samples.
• Further replication studies with new schizophrenia samples and analysis of encoded peptides in blood are warranted.